Empowering Clinicians. Advancing Cancer Care. Transforming Outcomes.

Thank You for Making CIO 2025 a Success

Thank you to everyone who joined us for the Symposium on Clinical Interventional Oncology (CIO) 2025. Your engagement, expertise, and enthusiasm made this year’s meeting an incredible success. Together, we explored the latest innovations in interventional oncology (IO), shared best practices, and advanced our shared mission to improve outcomes for patients with cancer.

From foundational techniques to emerging therapies, CIO 2025 brought together practitioners at every stage of their IO journey to learn, collaborate, and grow. The insights shared and connections made this year will continue to shape the future of IO for years to come.

If you attended CIO 2025, don’t forget — you have until November 19, 2025, to claim your CME/CE credit.

Highlights

300+

Attendees
80+

Practical IO Presentations
40+

Expert Faculty

Y90 Dosimetry Pre-Conference

Join us on October 16 for the Y90 Dosimetry Pre-Conference—an immersive workshop aimed at deepening your expertise in Y90 radioembolization dosimetry. This complimentary, interactive program combines theoretical knowledge with hands-on training in industry-leading tools such as MIM Y90 Dosimetry Software and the Cancer Y90 App. Participants will engage in simulated treatment planning across various therapeutic scenarios, enhancing their ability to connect dosimetry models with clinical outcomes and toxicity considerations. Designed to build both confidence and competence, this pre-conference is an essential experience for those looking to elevate their Y90 treatment planning and delivery.

The Topics

CIO offers real-world education through IO presentations, hands-on workshops, case reviews with the experts, and lessons learned from complications and saves.
- The Year in Review in IO
- Morbidity and Mortality in IO
- Fundamentals in IO
- Interventions for Prostate, Pancreatic, and Breast Cancers

View the Agenda

Meet the Pioneers

Full Faculty

CIO provided the optimal platform for collaboration among multidisciplinary specialties that participate in the management of oncology patients. The input from industry specialists and interventional radiologists with direct experience with their products offers a unique perspective on both FDA-approved and future therapy options. The encouragement provided to residents and fellows proves CIO remains dedicated to educating the future of IO specialists within the sphere of oncology."
Interventional radiology became a therapeutic paradigm in oncologic diagnosis and treatment. A masterful combination of the CIO sessions exquisitely covered pioneering techniques in embolization, ablative therapies, palliative care, non-opioid pain management, and IO practice business. Cutting-edge, minimally invasive technology, indulging virtual reality educational tools, and passion and skills of all the established IO leaders built for an exceptional CIO meeting. Truly inspired to keep fighting the good fight."
I really enjoyed this year's CIO meeting, with its emphasis on both the essentials for IO practice as well as the most up-to-date data review, practical skills, and lots of new ideas, expert recommendations, and upcoming therapies from elite interventional oncologists. The range of topics covered was excellent, and the format included the right balance between lectures, workshops, and interactive sessions."

Available Dates